(Q70878989)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7264915%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Dosage form design for improvement of bioavailability of levodopa IV: Possible causes of low bioavailability of oral levodopa in dogs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7264915%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

5 April 2024

author name string

K. Sasahara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7264915

5 April 2024

T. Nitanai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7264915

5 April 2024

T. Habara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7264915

5 April 2024

T. Kojima

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7264915

5 April 2024

Y. Kawahara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7264915

5 April 2024

T. Morioka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7264915

5 April 2024

E. Nakajima

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7264915

5 April 2024

language of work or name

English

0 references

publication date

1 July 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7264915%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 October 2019

https://api.elsevier.com/content/article/PII:S0022354915438031?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

https://api.elsevier.com/content/article/PII:S0022354915438031?httpAccept=text/plain

5 April 2024

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

Journal of Pharmaceutical Sciences

5 April 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7264915%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7264915%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7264915%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

730-733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7264915%20AND%20SRC:MED&resulttype=core&format=json

Dosage form design for improvement of bioavailability of levodopa II: bioavailability of marketed levodopa preparations in dogs and parkinsonian patients

14 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

Dosage form design for improvement of bioavailability of levodopa III: Influence of dose on pharmacokinetic behavior of levodopa in dogs and Parkinsonian patients

5 April 2024

2

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

The role of the liver in the clearance ofl-dopa from plasma

5 April 2024

4

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

Influence of route of administration on physiological availability of levodopa in dogs

5 April 2024

5

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

Minor Urinary Metabolites of L‐Dopa in the Rat

5 April 2024

6

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

Urinary Phenolic Compounds in Gnotobiotic and Conventional Rats on a Free Diet, and Before and after L-DOPA Loading on a Milk Diet*

5 April 2024

7

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

Journal of Pharmacology and Experimental Therapeutics

5 April 2024

8

186

160

Goldin

1971

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

Metabolism of drugs by microorganisms in the intestine

5 April 2024

9

1 reference

https://api.crossref.org/works/10.1002/JPS.2600700705

5 April 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7264915%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference